Topazian Mark, Aslanian Harry, Andersen Dana
Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street SW, Rochester, MN 55906, USA.
J Clin Gastroenterol. 2005 Nov-Dec;39(10):908-11. doi: 10.1097/01.mcg.0000180799.18834.99.
To assess outcomes following 6 months of endoscopic stenting for dominant pancreatic duct strictures in painful chronic pancreatitis.
Pancreatic stent placement may improve pain in chronic pancreatitis. Long-term outcomes after a 6-month period of stenting are unknown.
We identified all patients with chronic pancreatitis who underwent stenting of a dominant pancreatic duct stricture at one hospital. Stents were left in place for 6 months. Changes in weight, hospital visits, and narcotic use were analyzed.
Mean follow-up for the 15 subjects was 36 months; 87% improved following stent placement, and 11 (73%) completed 6 months of stent therapy. Hospital visits per subject decreased from 3.6 in the year prior to stent placement to 0.1 in the year after stent removal (P < 0.01). Oral narcotic use decreased from 33 mg MSO4/day in the month prior to stenting to 2 mg MSO4/day in the 12 months after stent removal (P = 0.01). Mean weight change was -5 kg in the year prior to stenting and +3.2 kg in the year after stent insertion (P < 0.01); 36% required endoscopic reintervention during the follow-up period.
Six months of stenting resulted in sustained clinical improvement in most patients with chronic pancreatitis and a dominant pancreatic duct stricture. Stenting was associated with subsequent weight gain, fewer hospital visits, and less narcotic use.
评估内镜下支架置入治疗疼痛性慢性胰腺炎主胰管狭窄6个月后的疗效。
胰管支架置入术可能改善慢性胰腺炎患者的疼痛症状。置入支架6个月后的长期疗效尚不清楚。
我们确定了在一家医院接受主胰管狭窄支架置入术的所有慢性胰腺炎患者。支架留置6个月。分析体重、就诊次数和麻醉药品使用情况的变化。
15名受试者的平均随访时间为36个月;87%的患者在支架置入后病情改善,11名(73%)患者完成了6个月的支架治疗。每位受试者的就诊次数从支架置入前一年的3.6次降至支架取出后一年的0.1次(P<0.01)。口服麻醉药品的使用量从支架置入前一个月的33mg硫酸吗啡/天降至支架取出后12个月的2mg硫酸吗啡/天(P=0.01)。支架置入前一年的平均体重变化为-5kg,支架置入后一年为+3.2kg(P<0.01);36%的患者在随访期间需要内镜再次干预。
对于大多数患有慢性胰腺炎和主胰管狭窄的患者,6个月的支架置入可带来持续的临床改善。支架置入与随后的体重增加、就诊次数减少和麻醉药品使用减少有关。